Buchi, Francesca <br/><br/>
Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid.  [electronic resource] 

 -  Leukemia research  Jul 2011 
 - 921-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-5835 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2011.01.033  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylation<br/>Apoptosis<br/>Benzamides<br/>Blotting, Western<br/>Cell Proliferation<br/>Drug Resistance, Neoplasm<br/>Electrophoresis, Gel, Two-Dimensional<br/>Fusion Proteins, bcr-abl--genetics<br/>Histone Deacetylase Inhibitors--therapeutic use<br/>Humans<br/>Imatinib Mesylate<br/>Immunoprecipitation<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Phosphotyrosine--metabolism<br/>Piperazines--adverse effects<br/>Protein Kinase Inhibitors--adverse effects<br/>Proteome--analysis<br/>Pyrimidines--adverse effects<br/>RNA, Messenger--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization<br/>Tumor Cells, Cultured<br/>Valproic Acid--therapeutic use